Virginia Kimball Dalton

Author

Dana-Farber Cancer Institute

Also Known As

Virginia K. Dalton, Virginia Kimball Dalton

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Maine Medical Center Barbara Bush Children’s Hospital University of Rochester Medical Center Ochsner Medical Center

About

Virginia Kimball Dalton is an author at Dana-Farber Cancer Institute specializing in hematology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	145
2	Health Sciences	1	1	11
3	Public Health	1	1	134
4	Immunology	1	1	11
5	Pharmacology	1	1	134

Virginia Kimball Dalton

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia Albert Moghrabi, Donna E. Levy, Barbara L. Asselin, Blood	2006	401
Childhood T-Cell Acute Lymphoblastic Leukemia: The Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Experience John M. Goldberg, Lewis B. Silverman, Donna E. Levy, Journal of Clinical Oncology	2003	346
Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia Craig A. Hurwitz, Lewis B. Silverman, Marshall A. Schorin, Cancer	2000	143
Doxorubicin Administration by Continuous Infusion Is Not Cardioprotective: The Dana-Farber 91-01 Acute Lymphoblastic Leukemia Protocol Steven E. Lipshultz, Amy Giantris, Stuart R. Lipsitz, Journal of Clinical Oncology Heart FailurePediatric Heart DiseaseCardiovascular PharmacologyBolus InfusionPharmacotherapy	2002	134
Height and Weight in Children Treated for Acute Lymphoblastic Leukemia: Relationship to CNS Treatment Virginia Kimball Dalton, Lewis B. Silverman, Richard D. Gelber, Journal of Clinical Oncology	2003	109
Induction failure in acute lymphoblastic leukemia of childhood Lewis B. Silverman, Richard D. Gelber, Mary Lynn Young, Cancer	1999	71
Outcomes of a Randomized Trial of Hyperfractionated Cranial Radiation Therapy for Treatment of High-Risk Acute Lymphoblastic Leukemia: Therapeutic Efficacy and Neurotoxicity Deborah P. Waber, Lewis B. Silverman, Lori Catania, Journal of Clinical Oncology	2004	46
Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia Craig A. Hurwitz, Lewis B. Silverman, Marshall A. Schorin, Cancer Prednisone ComplicatesImmunologyPharmacotherapyMetronomic ChemotherapyImmunotherapy	2000	11

Page 1